TrialPath

319 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

133 studies on the map

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide — Helios Clinical Research - Phoenix, PhoenixYouth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study — Children's National Hospital (CNH), Washington D.C.The CARING Study: Creating and Restoring Health Through Nutrition Guidance — Physicians Committee for Responsible Medicine, Washington D.C.A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) — CenExel Anaheim Clinical Trials, AnaheimA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes — Lakeview Clinical Research, GuntersvilleA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight — Uni of Alabama at Birmingham, BirminghamTrial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) — Arizona Clinical Trials - Pecos, ChandlerA Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus — Central Research Associates - Flourish - PPDS, BirminghamA Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) — University of Arizona, TucsonProact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease — Nephrology Consultants, HuntsvilleSafety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes — University of Alabama, BirminghamA Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies — Research Site, Little RockThe Reducing REVISITS Study: A Cluster RCT — University of Chicago, ChicagoSymptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS — Clinical Research of West Florida, Inc., ClearwaterA Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease. — University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, BirminghamDepemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2) — GSK Investigational Site, SheffieldA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006) — Research Site, FoleyEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype — Chandler Clinical Research Trials- Site Number : 8400025, ChandlerA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease — Research Site, BirminghamA Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD — SEC Clinical Research, LLC, DothanA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007) — Research Site, CullmanA Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — UAB Lung Health Center, BirminghamA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease — Research Site, AthensA Study to Evaluate Solrikitug in Participants With COPD (ZION) — University of Alabama at Birmingham Hospital, BirminghamA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease — University of Alabama at Birmingham Lung Health Center, BirminghamEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype — University of Alabama at Birmingham- Site Number : 8400003, BirminghamRademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD) — University of Alabama at Birmingham Lung Health Center, BirminghamGATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes — Medical Investigations, Little RockAn Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema — Banner University Medical Center, PhoenixTitrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia — State University of New York at Buffalo Jacobs School of Medicine and Biomedical Sciences, BuffalomyAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home — UAB School of Medicine/Lung Health Center, BirminghamHP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes — Alliance Clinical Canoga Park (Hope Clinical Research), Canoga ParkClinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD — University of Alabama, BirminghamA Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM — Clinical Trial Site, MontclairBronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3 — University of Alabama at Birmingham, BirminghamEfficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus — Lynn Institute of the Ozarks, Little RockA Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome — Clinical Research Institute of Arizona, Sun City WestEvaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes — Sansum Diabetes Research Institute, Santa BarbaraEffect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT — Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute), TorrancePhase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy — Central Research Associates, LLC dba Flourish Research, BirminghamPhase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets — Central Research Associates, LLC dba Flourish Research, BirminghamDepemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1) — GSK Investigational Site, Loxahatchee GrovesSPIROMICS Study of Early COPD Progression (SOURCE) — University of Alabama at Birmingham, BirminghamSTRIVE Post-Market Registry Study — Dignity Health St. Joseph's Hospital and Medical Center, PhoenixA Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP) — Equity Medical Bowling Green, Bowling GreenEfficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System — University of Southern California, Los AngelesTo Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment — DM Clinical Research - Phoenix, PhoenixMulti-Center Clean Air Randomized Controlled Trial in COPD — University of Alabama, Lung Health Center, BirminghamStudy to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus — Lenzmeier Family Medicine, GlendaleEvaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD — University of Alabama-Birmingham Hospital - UAB Lung Health Center, BirminghamImplementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD) — University of Alabama, BirminghamImplementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2) — University of Alabama, BirminghamCGM for Management of Type 2 Diabetes in Pregnancy — University of Alabama at Birmingham, BirminghamA Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease — University of Alabama at Birmingham, BirminghamBalance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems — OrthoArizona--Mesa Arbor Avenue, MesaeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation — GSK Investigational Site, DoralFunctional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention — Boise VA Medical Center, BoisePragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD — Minneapolis VA Health Care System, MinneapolisPiMZ Longitudinal Cohort (PiMZ Logic) — University of Alabama at Birmingham, BirminghamBreathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH — Rocky Mountain Regional VA Medical Center, Aurora, CO, AuroraFood and Fitness With Medicine (FFWM) — Ohio State Healthy Community Center, ColumbusCOPD Exacerbation Follow Up — Advocate Lutheran General Hospital, Park RidgeA Study of WIN378 in Participants With Moderate to Severe COPD (Sirius) — WB Contracted Clinical Research Site, Miami LakesIntegrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure — Johns Hopkins Community Physicians, BaltimoreMilitary Health and Nutrition Examination Study — Fort Campbell, Fort CampbellPRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD. — University of Colorado, DenverA Multi Center Study Testing a New Implant for Adults With Severe Emphysema — University of California, San Francisco, San FranciscoEffect of Ensifentrine on Sputum Markers of Inflammation in COPD — University of Alabama at Birmingham, BirminghamLung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers — Zuckerberg San Francisco General Hospital and Trauma Center, San FranciscoExercise and Intranasal Insulin in Type 2 Diabetes — Robert Wood Johnson University Hospital Clinical Research Center, New BrunswickClosed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital — The University of Alabama at Birmingham, BirminghamExtracellular Vesicles, Insulin Action, and Exercise — Institute for Food, Nutrition, and Health, New BrunswickMechanisms of Fatigability With Diabetes — University of Michigan, Ann ArborSafety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes — SUNY Upstate Medical Center, AlbanyStudy to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency — Syneos Miami, MiamiRehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD — Zuckerberg San Francisco General (ZSFG) Hospital, San FranciscoBrain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D) — Washington University School of Medicine, St LouisPuberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study) — Children's Hospital Colorado, AuroraStudy of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D — Clinical Pharmacology of Miami, MiamiDietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy — University South Carolina, ColumbiaRole of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes — University of Colorado, AuroraImproving Appetite Self-Regulation in African American Adults With Type 2 Diabetes — Rachel W. Goode, KannapolisNormal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide — Stanford University, Palo AltoEnhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients — One Robert Wood Johnson Place, New BrunswickCGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes — Jefferson Health New Jersey, SewellImplementation of Team Clinic for Type 2 Diabetes (TCT2) — Children's Hospital Los Angeles, Los AngelesQuantifying Hepatic Mitochondrial Fluxes in Humans — Texas Diabetes Institute - University Health System, San AntonioEvaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care. — WoundCentrics Wound Care & Hyperbarics -Corpus Christi - Shoreline, Corpus ChristiTreating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification — University of Colorado Department of Family Medicine, AuroraPrecision Dosing of Metformin in Youth With T2D — UCSF Benioff Children's Hospital Oakland, Pediatric Diabetes Clinic, OaklandEffectiveness of and Implementation Strategies for 'Disfrutando'. — University of Missouri, ColumbiaPrimary Care Pragmatic, Real World Experience for Automated Insulin Delivery — University of Colorado Anschutz Medical Campus, AuroraVirtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy — Rutgers Health Family Medicine at Monument Square, New BrunswickAddressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US — Duke University - Charlotte Study Sites, CharlotteComparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes — University Health System Texas Diabetic Institute, San AntonioGlycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes — University Health - Texas Diabetic Institute, San AntonioDiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes — Childrens hospital colorado, DenverEnhancing Diabetes Care: Exposome &Amp; Sensors — University of Illinois - Chicago, ChicagoHome Hospital for Suddenly Ill Adults — Brigham and Women's Hospital, BostonDeveloping and Testing a Self-Compassion Tool Kit to Improve the Care of Individuals With Type 2 Diabetes — University of California, San Diego, San DiegoAchieving Routine Intervention and Screening for Emotional Health — University of Chicago, ChicagoSupporting Evidence-based Responses to Emotional Needs in Emphysema — Henry Ford Health System, DetroitMindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF — VA Boston, BostonLung and Bone Marrow Transplantation for Lung and Bone Marrow Failure — UPMC Presbyterian, PittsburghAcoustic Waveform Respiratory Evaluation — Indiana University, IndianapolisSite and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap — Arthur F Gelb MD, LakewoodEffectiveness of the WearME System for COPD Severity and Respiratory Function — Johns Hopkins, BaltimorePulmonary Rehabilitation for Rural Patients With COPD — Mayo Clinic in Arizona, ScottsdaleGut Microbiota in Metabolic Surgery — Vanderbilt_University MC, NashvilleKetogenic Diet and Diabetes Demonstration Project — University of New Mexico, AlbuquerqueExercise and Protein Efficiency in T2D — Freer Hall - University of Illinois, UrbanaThe Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults — Translational Research Institute for Metabolism and Diabetes, OrlandoFeasibility of Semaglutide in Advanced Lung Disease — University of Pennsylvania Perelman School of Medicine, PhiladelphiaDiabetes Reversal Online Program and Study (DROP Study) — Physician Committee for Responsible Medicine, Washington D.C.Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants — Texas Diabetes Institute/UH, San AntonioPreventing Type 2 Diabetes in Black Emergent Adult — UNC-Chapel Hill, Chapel HillNutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics — Joslin Diabetes Center, BostonContinuous Glucose Monitor Use in Pregnancy — University of Massachusetts Memorial Medical Center, WorcesterBrown Adipose Tissue Activation by Spinal Cord Stimulation — Oregon Health & Science University, PortlandEffect of Sleep Extension on Ceramides in People with Overweight and Obesity — College of Health Research Complex--University of Utah, Salt Lake CityPilot of Continuous Glucose Monitor-Augmented Food Is Medicine — University of North Carolina at Chapel Hill, Chapel HillAdapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents — USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, HoustonInterprofessional Pharmacogenomics (IPGx) Registry and Repository — Texas A&M Family Care, BryanTrial to Determine Effective Aspirin Dose in COPD — Johns Hopkins Bayview Medical Center, BaltimoreTime Limited Eating in Adolescents With Type 2 Diabetes (KT2D) — Children's Hospital of Los Angeles, Los AngelesCircadian Intervention to Improve Cardiometabolic Health — College of Health Research Complex--University of Utah, Salt Lake CityEffects of Ketone Ester Consumption on Exercise Tolerance and Cardiac Function — The Ross Heart Hospital, ColumbusUnderstanding Metabolism and Inflammation Risks for Diabetes in Adolescents — University of Michigan, Ann ArborUsing Virtual Reality to Improve Medical Training — Ohio University, AthensSubclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease — Brigham and Women's Hospital, BostonCOPD Patient-Powered Research Network — COPD Foundation, Washington D.C.Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy — University South Carolina, ColumbiaUsing Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes — Stanford University, Stanford

Showing the 150 nearest — narrow your filters for fewer, closer studies.